.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKinsey
Queensland Health
McKesson
Fuji
Johnson and Johnson
QuintilesIMS
UBS
Harvard Business School
Merck

Generated: November 25, 2017

DrugPatentWatch Database Preview

TRANXENE Drug Profile

« Back to Dashboard

Which patents cover Tranxene, and what generic Tranxene alternatives are available?

Tranxene is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in TRANXENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.

Pharmacology for TRANXENE

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for TRANXENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-008Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-007Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TRANXENE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-008Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Dow
QuintilesIMS
Julphar
AstraZeneca
Moodys
Citi
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot